Cancer-related gene expression is associated with disease severity and modifiable lifestyle factors in non-alcoholic fatty liver disease
Bianca M. Arendt(University Health Network), Johane P. Allard(University Health Network), Paulina Pettinelli(University Health Network), Elena M. Comelli(University of Toronto), David W.L.(University of Guelph), Scott Fung(Toronto General Hospital), Ian D. McGilvray(Toronto General Hospital), Sandra E. Fischer(University Health Network), Anastasia Teterina(University of Oregon)
Cited by 44
Related Papers
Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial
|Clinical Cancer Research|2017|635
The Impact of COVID-19 on Health Behavior, Stress, Financial and Food Security among Middle to High Income Canadian Families with Young Children
|Nutrients|2020|593
Comprehensive Profiling of Plasma Fatty Acid Concentrations in Young Healthy Canadian Adults
|PLoS ONE|2015|367
Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n‐3 and n‐6 polyunsaturated fatty acids
|Hepatology|2015|348
Are all n-3 polyunsaturated fatty acids created equal?
|Lipids in Health and Disease|2009|333